Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs.
Fares Al MohamadValeria Rios RodriguezHildrun HaibelMikhail ProtopopovJudith RademacherJoachim SieperMurat TorğutalpHenriette KädingFabian ProftDenis PoddubnyyPublished in: RMD open (2024)
Both NoP and NP components seem to be associated with residual symptoms in patients with r-axSpA receiving treatment with bDMARDs.